Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $3.07M in the quarter ending September 30, 2024, with 58.13% growth. This brings the company's revenue in the last twelve months to $13.45M, down -87.34% year-over-year. In the year 2023, Fate Therapeutics had annual revenue of $63.53M, down -34.03%.

• Revenue (ttm): $13.45M
• Revenue Growth: -87.34%
• P/S Ratio: 13.60
• Revenue / Employee: $74,293
• Employees: 181
• Market Cap: 191.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	63.53M	-32.77M	-34.03%
Dec 31, 2022	96.30M	40.45M	72.44%
Dec 31, 2021	55.85M	24.41M	77.66%
Dec 31, 2020	31.43M	20.75M	194.33%
Dec 31, 2019	10.68M	5.94M	125.32%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.